V025-2565 Screening compound: 4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide

V025-2565 Screening compound: 4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide
V025-2565 Screening compound: 4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2565
4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2565

Molecular Formula

C25H29N3O5S (C25 H29 N3 O5 S)

Compound Name

4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide

IUPAC name

4-methoxy-N-{[1-(2-methoxyethyl)-2-phenylmethanesulfonyl-1H-imidazol-5-yl]methyl}-N-(prop-2-en-1-yl)benzamide

SMILES

COCCn1c(S(Cc2ccccc2)(=O)=O)ncc1CN(CC=C)C(c(cc1)ccc1OC)=O

InChI

InChI=1S/C25H29N3O5S/c1-4-14-27(24(29)21-10-12-23(33-3)13-11-21)18-22-17-26-25(28(22)15-16-32-2)34(30,31)19-20-8-6-5-7-9-20/h4-13,17H,1,14-16,18-19H2,2-3H3

InChI Key

KWLPWXYDGQGQKO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19818873

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

483.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.654

Distribution Coefficient, logD

2.654

Water Solubility, LogSw

-2.84

Polar Surface Area

72.977

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

-3.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

V025-2565 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V025-2565 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2565?
Check Price and Availability of V025-2565, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2565 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2565
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2565
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2565 available by request